Gene · 7423
Papers4,111
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,111
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell RNA sequencing reveals neurovascular-osteochondral network crosstalk during temporomandibular joint osteoarthritis: Pilot study in a human condylar cartilage. | Heliyon | 2023 | 37867837 | PubTator, text mining | PubMed |
| From signalling pathways to targeted therapies: unravelling glioblastoma's secrets and harnessing two decades of progress. | Signal Transduct Target Ther | 2023 | 37857607 | PubTator, text mining | PubMed |
| Turnover of Microaneurysms After Intravitreal Injections of Faricimab for Diabetic Macular Edema. | Invest Ophthalmol Vis Sci | 2023 | 37856112 | PubTator, text mining | PubMed |
| Single-cell characterization of self-renewing primary trophoblast organoids as modeling of EVT differentiation and interactions with decidual natural killer cells. | BMC Genomics | 2023 | 37853336 | PubTator, text mining | PubMed |
| Unraveling the hypoxia modulating potential of VEGF family genes in pan-cancer. | Genomics Inform | 2023 | 37852616 | PubTator, text mining | PubMed |
| LAIR1 drives glioma progression by nuclear focal adhesion kinase dependent expressions of cyclin D1 and immunosuppressive chemokines/cytokines. | Cell Death Dis | 2023 | 37845206 | PubTator, text mining | PubMed |
| Macrophage/microglia polarization for the treatment of diabetic retinopathy. | Front Endocrinol (Lausanne) | 2023 | 37842315 | PubTator, text mining | PubMed |
| Mechanistic Insight into Age-Related Macular Degeneration (AMD): Anatomy, Epidemiology, Genetics, Pathogenesis, Prevention, Implications, and Treatment Strategies to Pace AMD Management. | Chonnam Med J | 2023 | 37840684 | PubTator, text mining | PubMed |
| Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. | Mol Cancer | 2023 | 37833788 | PubTator, text mining | PubMed |
| An Update on Strategies to Deliver Protein and Peptide Drugs to the Eye. | ACS Omega | 2023 | 37810716 | PubTator, text mining | PubMed |
| Exosome-bearing hydrogels and cardiac tissue regeneration. | Biomater Res | 2023 | 37803483 | PubTator, text mining | PubMed |
| Outcomes of hypothalamic oxytocin neuron-driven cardioprotection after acute myocardial infarction. | Basic Res Cardiol | 2023 | 37801130 | PubTator, text mining | PubMed |
| RAMP1 as a novel prognostic biomarker in pan-cancer and osteosarcoma. | PLoS One | 2023 | 37796823 | PubTator, text mining | PubMed |
| Panretinal photocoagulation plus intravitreal conbercept for diabetic retinopathy in real world: a retrospective study. | BMC Ophthalmol | 2023 | 37794367 | PubTator, text mining | PubMed |
| A Novel Gene Pair CSTF2/DPE2A Impacts Prognosis and Cell Cycle of Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 37791068 | PubTator, text mining | PubMed |
| The role of angiogenic growth factors in the immune microenvironment of glioma. | Front Oncol | 2023 | 37790751 | PubTator, text mining | PubMed |
| Efficacy of a single injection of brolucizumab in neovascular age-related macular degeneration on visual acuity and micromorphometry. | Indian J Ophthalmol | 2023 | 37787238 | PubTator, text mining | PubMed |
| Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. | Mol Cancer | 2023 | 37784082 | PubTator, text mining | PubMed |
| Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) alleviate excessive autophagy of ovarian granular cells through VEGFA/PI3K/AKT/mTOR pathway in premature ovarian failure rat model. | J Ovarian Res | 2023 | 37777781 | PubTator, text mining | PubMed |
| Vascular Endothelial Growth Factor Family and Head and Neck Squamous Cell Carcinoma. | Anticancer Res | 2023 | 37772546 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7423/papers?page=14